On ECHEMI
Home > Drugs > Heart failure
Heart failure
Heart failure, also known as "myocardial failure", refers to the inability of the heart to pump out blood in proportion to the venous return and body tissue metabolism. It is often caused by various diseases that weaken the myocardial contractility, thereby reducing the heart's blood output, which is insufficient to meet the body's needs, and thus produces a series of symptoms and signs.
Related Drugs
Bumetanide for injection
Indication: 1. Edema diseases: including congestive heart failure, cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons), especially when other diuretics are ineffective, this type of drug may still be effective. Combined with other drugs to treat acute pulmonary edema and acute cerebral edema. 2. Hypertension: In the gradient therapy of hypertension, it is not the first choice for the treatment of essential hypertension, but when thiazide drugs are ineffective, especially when accompanied by renal insufficiency or hypertensive crisis, this type of drug is particularly suitable. 3. Prevention of acute renal failure: used for various reasons leading to insufficient renal blood perfusion, such as dehydration, shock, poisoning, anesthesia accidents and circulatory insufficiency, timely application while correcting insufficient blood volume can reduce the chance of acute tubular necrosis. 4. Hyperkalemia and hypercalcemia. 5. Dilutional hyponatremia: especially when the blood sodium concentration is lower than 120mmol/L. 6. Syndrome of excessive secretion of antidiuretic hormone (SIADH). 7. Treatment of acute drug poisoning, such as barbiturate poisoning, etc. 8. It may still be effective in some cases where furosemide is ineffective.
Manufacturer:

Guangdong Jianxin Pharmaceutical Co., Ltd.

Bumetanide for injection
Indication: 1. Edema diseases: including congestive heart failure, cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons), especially when other diuretics are ineffective, this type of drug may still be effective. Combined with other drugs to treat acute pulmonary edema and acute cerebral edema. 2. Hypertension: In the gradient therapy of hypertension, it is not the first choice for the treatment of essential hypertension, but when thiazide drugs are ineffective, especially when accompanied by renal insufficiency or hypertensive crisis, this type of drug is particularly suitable. 3. Prevention of acute renal failure: used for various reasons leading to insufficient renal blood perfusion, such as dehydration, shock, poisoning, anesthesia accidents and circulatory insufficiency, timely application while correcting insufficient blood volume can reduce the chance of acute tubular necrosis. 4. Hyperkalemia and hypercalcemia. 5. Dilutional hyponatremia: especially when the blood sodium concentration is lower than 120mmol/L. 6. Syndrome of excessive secretion of antidiuretic hormone (SIADH). 7. Treatment of acute drug poisoning, such as barbiturate poisoning, etc. 8. It may still be effective in some cases where furosemide is ineffective.
Manufacturer:

Hangzhou Guoguang Pharmaceutical Co., Ltd.

Bumetanide for injection
Indication: 1. Edema diseases: including congestive heart failure, cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons), especially when other diuretics are ineffective, this type of drug may still be effective. Combined with other drugs to treat acute pulmonary edema and acute cerebral edema. 2. Hypertension: In the gradient therapy of hypertension, it is not the first choice for the treatment of essential hypertension, but when thiazide drugs are ineffective, especially when accompanied by renal insufficiency or hypertensive crisis, this type of drug is particularly suitable. 3. Prevention of acute renal failure: used for various reasons leading to insufficient renal blood perfusion, such as dehydration, shock, poisoning, anesthesia accidents and circulatory insufficiency, timely application while correcting insufficient blood volume can reduce the chance of acute tubular necrosis. 4. Hyperkalemia and hypercalcemia. 5. Dilutional hyponatremia: especially when the blood sodium concentration is lower than 120mmol/L. 6. Syndrome of excessive secretion of antidiuretic hormone (SIADH). 7. Treatment of acute drug poisoning, such as barbiturate poisoning, etc. 8. It may still be effective in some cases where furosemide is ineffective.
Manufacturer:

Hangzhou Guoguang Pharmaceutical Co., Ltd.

Vitamin B6 Injection
Indication: 1. Suitable for the prevention and treatment of vitamin B6 deficiency, prevention and treatment of isoniazid poisoning; can also be used for vomiting caused by pregnancy, radiation sickness and anticancer drugs, seborrheic dermatitis, etc. 2. Vitamin B6 supplementation during total parenteral nutrition and malnutrition due to insufficient intake, and progressive weight loss. 3. The following situations increase the need for vitamin B6: pregnancy and lactation, hyperthyroidism, burns, long-term chronic infection, fever, congenital metabolic disorders (cystathionuria, hyperoxalate disease, homocystinuria, xanthine aciduria), congestive heart failure, long-term hemodialysis, malabsorption syndrome with hepatobiliary system diseases (such as alcoholism with cirrhosis), intestinal diseases (celiac disease, tropical stomatitis
Isosorbide Mononitrate for Injection
Indication: It is suitable for the treatment of angina pectoris and can be used in combination with digitalis and (or) diuretics to treat chronic heart failure.
Isosorbide Mononitrate for Injection
Indication: It is suitable for the treatment of angina pectoris and can be used in combination with digitalis and (or) diuretics to treat chronic heart failure.
Manufacturer:

Zhejiang Apeloa Kangyu Pharmaceutical Co., Ltd.

Isosorbide Mononitrate for Injection
Indication: It is suitable for the treatment of angina pectoris and can be used in combination with digitalis and (or) diuretics to treat chronic heart failure.
Manufacturer:

Hainan Huluwa Pharmaceutical Group Co., Ltd.

Digitalis glycoside tablets
Indication: It is mainly used for congestive heart failure. Because of its slow and lasting effect, it is suitable for long-term use by patients with chronic heart failure. It is especially suitable for patients with congestive heart failure accompanied by renal impairment.
Isosorbide mononitrate sustained-release capsules (Ⅲ)
Indication: Long-term treatment of coronary heart disease; prevention of angina pectoris; treatment of persistent angina pectoris after myocardial infarction; combined with digitalis and/or diuretics to treat chronic congestive heart failure.
Manufacturer:

Shanghai Ethypharm Pharmaceuticals Co., Ltd.

Isosorbide mononitrate sustained-release capsules (Ⅰ)
Indication: Used to prevent angina pectoris; treat persistent angina pectoris after myocardial infarction and coronary heart disease; used in combination with digitalis or diuretics to treat chronic congestive heart failure.
Manufacturer:

Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.